Список литературы

Поставить закладку

Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7 // Obstetrics and Gynecology. – 2023. – Т. 142. – Management of Premenstrual Disorders. – № 6. – С. 1516-1533.
Premenstrual dysphoric disorder: evidence for a new category for DSM-5 / C. N. Epperson, M. Steiner, S. A. Hartlage [и др.] // The American Journal of Psychiatry. – 2012. – Т. 169. – Premenstrual dysphoric disorder. – № 5. – С. 465-475.
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus / P. M. S. O’Brien, T. Bäckström, C. Brown [и др.] // Archives of Women’s Mental Health. – 2011. – Т. 14. – Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders. – № 1. – С. 13-21.
ISPMD consensus on the management of premenstrual disorders / T. Nevatte, P. M. S. O’Brien, T. Bäckström [и др.] // Archives of Women’s Mental Health. – 2013. – Т. 16. – № 4. – С. 279-291.
Leminen, H. [PMS and PMDD] / H. Leminen, J. Paavonen // Duodecim; Laaketieteellinen Aikakauskirja. – 2013. – Т. 129. – № 17. – С. 1756-1763.
Yonkers, K. A. Evidence-Based Treatments for Premenstrual Disorders / K. A. Yonkers, M. Simoni // American Journal of Obstetrics and Gynecology. – 2018. – Т. 219. – № 2. – С. 215-216.
Hantsoo, L. Premenstrual Dysphoric Disorder: Epidemiology and Treatment / L. Hantsoo, C. N. Epperson // Current Psychiatry Reports. – 2015. – Т. 17. – Premenstrual Dysphoric Disorder. – № 11. – С. 87.
Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels / P. J. Schmidt, P. E. Martinez, L. K. Nieman [и др.] // The American Journal of Psychiatry. – 2017. – Т. 174. – Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression. – № 10. – С. 980-989.
Whole-blood serotonin in premenstrual syndrome / A. J. Rapkin, E. Edelmuth, L. C. Chang [и др.] // Obstetrics and Gynecology. – 1987. – Т. 70. – № 4. – С. 533-537.
Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome / J. F. Steege, A. L. Stout, D. L. Knight, C. B. Nemeroff // American Journal of Obstetrics and Gynecology. – 1992. – Т. 167. – № 1. – С. 168-172.
Serotonin levels and platelet uptake during premenstrual tension / D. L. Taylor, R. J. Mathew, B. T. Ho, M. L. Weinman // Neuropsychobiology. – 1984. – Т. 12. – № 1. – С. 16-18.
Selective serotonin reuptake inhibitors for premenstrual syndrome / J. Marjoribanks, J. Brown, P. M. S. O’Brien, K. Wyatt // The Cochrane Database of Systematic Reviews. – 2013. – Т. 2013. – № 6. – С. CD001396.
Hantsoo, L. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle / L. Hantsoo, C. N. Epperson // Neurobiology of Stress. – 2020. – Т. 12. – Allopregnanolone in premenstrual dysphoric disorder (PMDD). – С. 100213.
Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons / T. Bäckström, D. Haage, M. Löfgren [и др.] // Neuroscience. – 2011. – Т. 191. – С. 46-54.
A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder / T. Bäckström, K. Ekberg, A. L. Hirschberg [и др.] // Psychoneuroendocrinology. – 2021. – Т. 133. – С. 105426.
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder / P. E. Martinez, D. R. Rubinow, L. K. Nieman [и др.] // Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. – 2016. – Т. 41. – № 4. – С. 1093-1102.
Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial / M. Bixo, K. Ekberg, I. S. Poromaa [и др.] // Psychoneuroendocrinology. – 2017. – Т. 80. – С. 46-55.
Bäckström, T. Positive GABAA receptor modulating steroids and their antagonists: Implications for clinical treatments / T. Bäckström, R. Das, M. Bixo // Journal of Neuroendocrinology. – 2022. – Т. 34. – Positive GABAA receptor modulating steroids and their antagonists. – № 2. – С. e13013.
Allopregnanolone levels before and after selective serotonin reuptake inhibitor treatment of premenstrual symptoms / C. R. Gracia, E. W. Freeman, M. D. Sammel [и др.] // Journal of Clinical Psychopharmacology. – 2009. – Т. 29. – № 4. – С. 403-405.
Griffin, L. D. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes / L. D. Griffin, S. H. Mellon // Proceedings of the National Academy of Sciences of the United States of America. – 1999. – Т. 96. – № 23. – С. 13512-13517.
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial / K. A. Yonkers, S. G. Kornstein, R. Gueorguieva [и др.] // JAMA psychiatry. – 2015. – Т. 72. – Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder. – № 10. – С. 1037-1044.
Dennerstein, L. Epidemiology of premenstrual symptoms and disorders / L. Dennerstein, P. Lehert, K. Heinemann // Menopause International. – 2012. – Т. 18. – № 2. – С. 48-51.
Steiner, M. The premenstrual symptoms screening tool (PSST) for clinicians / M. Steiner, M. Macdougall, E. Brown // Archives of Women’s Mental Health. – 2003. – Т. 6. – № 3. – С. 203-209.
Health and economic impact of the premenstrual syndrome / J. E. Borenstein, B. B. Dean, J. Endicott [и ёдр.] // The Journal of Reproductive Medicine. – 2003. – Т. 48. – № 7. – С. 515-524.
Adewuya, A. O. Pattern and correlates of premenstrual symptomatology amongst Nigerian University students / A. O. Adewuya, O. M. Loto, T. A. Adewumi // Journal of Psychosomatic Obstetrics and Gynaecology. – 2009. – Т. 30. – № 2. – С. 127-132.
Rapkin, A. J. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness / A. J. Rapkin, S. A. Winer // Expert Review of Pharmacoeconomics & Outcomes Research. – 2009. – Т. 9. – Premenstrual syndrome and premenstrual dysphoric disorder. – № 2. – С. 157-170.
Hylan, T. R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France / T. R. Hylan, K. Sundell, R. Judge // Journal of Women’s Health & Gender-Based Medicine. – 1999. – Т. 8. – The impact of premenstrual symptomatology on functioning and treatment-seeking behavior. – № 8. – С. 1043-1052.
Kadian, S. Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders / S. Kadian, S. O’Brien // Menopause International. – 2012. – Т. 18. – № 2. – С. 43-47.
Yonkers, K. A. Premenstrual syndrome / K. A. Yonkers, P. M. S. O’Brien, E. Eriksson // Lancet (London, England). – 2008. – Т. 371. – № 9619. – С. 1200-1210.
Takeda, T. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder / T. Takeda // The Journal of Obstetrics and Gynaecology Research. – 2023. – Т. 49. – Premenstrual disorders. – № 2. – С. 510-518.
Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey / J. Potter, J. Bouyer, J. Trussell, C. Moreau // Journal of Women’s Health (2002). – 2009. – Т. 18. – Premenstrual syndrome prevalence and fluctuation over time. – № 1. – С. 31-39.
Core Symptoms That Discriminate Premenstrual Syndrome / E. W. Freeman, S. M. Halberstadt, K. Rickels [и др.]. – Текст : электронный // Journal of Women’s Health. – 2011. – Т. 20. – № 1. – С. 29-35. – URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017419/ (дата обращения: 01.05.2024).
Gudipally, P. R. Premenstrual Syndrome / P. R. Gudipally, G. K. Sharma. – Текст : электронный // StatPearls. – Treasure Island (FL) : StatPearls Publishing, 2024. – URL: http://www.ncbi.nlm.nih.gov/books/NBK560698/ (дата обращения: 24.06.2024).
Diagnostic and statistical manual of mental disorders: DSM-5^TM, 5th ed : Diagnostic and statistical manual of mental disorders: DSM-5^TM, 5th ed. Diagnostic and statistical manual of mental disorders. – Arlington, VA, US : American Psychiatric Publishing, Inc., 2013. – xliv, 947 с.
Interdisciplinary consensus on management of premenstrual disorders in Switzerland / P. Stute, C. Bodmer, U. Ehlert [и др.] // Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology. – 2017. – Т. 33. – № 5. – С. 342-348.
Mishra, S. Premenstrual Dysphoric Disorder / S. Mishra, H. Elliott, R. Marwaha. – Текст : электронный // StatPearls. – Treasure Island (FL) : StatPearls Publishing, 2024. – URL: http://www.ncbi.nlm.nih.gov/books/NBK532307/ (дата обращения: 24.06.2024).
Yan, H. Suicidality in patients with premenstrual dysphoric disorder-A systematic review and meta-analysis / H. Yan, Y. Ding, W. Guo // Journal of Affective Disorders. – 2021. – Т. 295. – С. 339-346.
Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review / E. Osborn, J. Brooks, P. M. S. O’Brien, A. Wittkowski // Archives of Women’s Mental Health. – 2021. – Т. 24. – Suicidality in women with Premenstrual Dysphoric Disorder. – № 2. – С. 173-184.
Association of Premenstrual Dysphoric Disorder and Eating Behaviors Among Nursing Students: A Cross-Sectional Study / Ö. G. Çoban, D. Karakaya, A. Önder [и др.] // Journal of Pediatric and Adolescent Gynecology. – 2021. – Т. 34. – Association of Premenstrual Dysphoric Disorder and Eating Behaviors Among Nursing Students. – № 2. – С. 203-208.
Addictive behaviors across the menstrual cycle: a systematic review / K. M. Joyce, K. P. Good, P. Tibbo [и др.] // Archives of Women’s Mental Health. – 2021. – Т. 24. – Addictive behaviors across the menstrual cycle. – № 4. – С. 529-542.
Diagnosis and management of premenstrual disorders / S. O’Brien, A. Rapkin, L. Dennerstein, T. Nevatte // BMJ (Clinical research ed.). – 2011. – Т. 342. – С. d2994.
Management of Premenstrual Syndrome: Green-top Guideline No. 48 // BJOG: an international journal of obstetrics and gynaecology. – 2017. – Т. 124. – Management of Premenstrual Syndrome. – № 3. – С. e73-e105.
https://phlebounion.ru - Национальные критерии приемлемости контрацепции 2023. – URL: https://phlebounion.ru/news/natsionalnyye-kriterii-priyemlemosti-kontratseptsii-2023-108 (дата обращения: 01.05.2024). – Текст : электронный.
Предменструальный синдром и мастопатия | #06/16 | «Лечащий врач» – профессиональное медицинское издание для врачей. Научные статьи. – URL: https://www.lvrach.ru/2016/06/15436498 (дата обращения: 02.09.2024). – Текст : электронный.
Masho, S. W. Obesity as a risk factor for premenstrual syndrome / S. W. Masho, T. Adera, J. South-Paul // Journal of Psychosomatic Obstetrics and Gynaecology. – 2005. – Т. 26. – № 1. – С. 33-39.
Prevalence and Associated Factors of Premenstrual Syndrome in Chinese Adolescent Girls / X. Liu, Z.-Z. Liu, Y. Yang, C.-X. Jia // Child Psychiatry and Human Development. – 2023.
Mukherjee, P. A Study to Assess the Relationship of Menstrual Irregularities with Nutritional Status among Adolescent Girls in Selected Urban Schools / P. Mukherjee. – 2018. – Vol. 8. – № 6.
Nutritional Status and Anthropometric Indices in relation to Menstrual Disorders: A Cross-Sectional Study / R. Taheri, F. Mesbah Ardekani, H. Raeisi Shahraki [и др.] // Journal of Nutrition and Metabolism. – 2020. – Т. 2020. – Nutritional Status and Anthropometric Indices in relation to Menstrual Disorders. – С. 5980685.
Dwivedi, D. Prevalence of Menstrual Disorder in Women and Its Correlation to Body Mass Index and Physical Activity / D. Dwivedi, N. Singh, U. Gupta // Journal of Obstetrics and Gynaecology of India. – 2024. – Т. 74. – № 1. – С. 80-87.
Factors associated with the severity of premenstrual symptoms in women with central obesity: a cross-sectional study / P. Sharifan, A. Jafarzadeh Esfehani, A. Zamiri [и др.]. – Текст : электронный // Journal of Health, Population, and Nutrition. – 2023. – Т. 42. – Factors associated with the severity of premenstrual symptoms in women with central obesity. – С. 9. – URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926716/ (дата обращения: 01.05.2024).
Опыт Клинического Применения Препарата «Vitex Agnus Castus» У Пациенток С Предменструальным Синдромом / С. Н. Рыжкова, К. Ш. Курбанова, А. Ф. Габбас, А. А. Нурллина. – Текст : электронный. – 2017. – С. 43-44. – URL: https://elibrary.ru/item.asp?ysclid=m0txo5dp6t783326485&id=28513997 (дата обращения: 08.09.2024).
ЭБС НГМУ: Гинекология национальное руководство ред. Г. М. Савельева [и др.]. – URL: https://library.ngmu.ru/search/view?mfn=116893&irbisBase=MAIN (дата обращения: 16.09.2024). – Текст : электронный.
Gonadotrophin‐releasing hormone analogues for endometriosis: bone mineral density / J. E. Farmer, A. Prentice, A. Breeze [и др.]. – Текст : электронный // The Cochrane Database of Systematic Reviews. – 2003. – Т. 2003. – Gonadotrophin‐releasing hormone analogues for endometriosis. – № 4. – С. CD001297. – URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027701/ (дата обращения: 01.05.2024).
The effectiveness of GnRHa with and without «add-back» therapy in treating premenstrual syndrome: a meta analysis / K. M. Wyatt, P. W. Dimmock, K. M. K. Ismail [и др.] // BJOG: an international journal of obstetrics and gynaecology. – 2004. – Т. 111. – The effectiveness of GnRHa with and without «add-back» therapy in treating premenstrual syndrome. – № 6. – С. 585-593.
Osteoporosis: assessing the risk of fragility fracture : National Institute for Health and Care Excellence: Guidelines. Osteoporosis. – London : National Institute for Health and Care Excellence (NICE), 2017. – URL: http://www.ncbi.nlm.nih.gov/books/NBK554920/ (дата обращения: 01.05.2024). – Текст : электронный.
Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials / A. E. de Wit, Y. A. de Vries, M. K. de Boer [и др.] // American Journal of Obstetrics and Gynecology. – 2021. – Т. 225. – Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome. – № 6. – С. 624-633.
Ma, S. Oral contraceptives containing drospirenone for premenstrual syndrome / S. Ma, S. J. Song // The Cochrane Database of Systematic Reviews. – 2023. – Т. 6. – № 6. – С. CD006586.
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation / T. B. Pearlstein, G. A. Bachmann, H. A. Zacur, K. A. Yonkers // Contraception. – 2005. – Т. 72. – № 6. – С. 414-421.
Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder / J. Marr, K. Heinemann, M. Kunz, A. Rapkin // International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics. – 2011. – Т. 113. – № 2. – С. 103-107.
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder / K. A. Yonkers, C. Brown, T. B. Pearlstein [и др.] // Obstetrics and Gynecology. – 2005. – Т. 106. – № 3. – С. 492-501.
Itriyeva, K. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents : Menstrual Issues in Adolescents – Part I: General Concerns / K. Itriyeva. – Текст : электронный // Current Problems in Pediatric and Adolescent Health Care. – 2022. – Т. 52. – № 5. – С. 101187. – URL: https://www.sciencedirect.com/science/article/pii/S1538544222000566 (дата обращения: 03.07.2024).
Предменструальный синдром: возможности дифференцированного подхода к лечению » Акушерство и Гинекология. – URL: https://aig-journal.ru/articles/Predmenstrualnyi-sindrom-vozmojnosti-differencirovanngo-podhoda-k-lecheniu.html (дата обращения: 02.05.2024). – Текст : электронный.
Сочетание предменструального синдрома и дисменореи у молодых женщин: особенности ведения. – URL: https://umedp.ru/articles/sochetanie_predmenstrualnogo_sindroma_i_dismenorei_u_molodykh_zhenshchin_osobennosti_vedeniya.html (дата обращения: 25.08.2024). – Текст : электронный.
В.н, П. Предменструальный синдром: эффективность лечения дроспиренон-содержащим контрацептивным препаратом / П. В.н, Л. А.в. – Текст : электронный // Медицинский совет. – 2015. – Предменструальный синдром. – № 9. – С. 49-53. – URL: https://cyberleninka.ru/article/n/predmenstrualnyy-sindrom-effektivnost-lecheniya-drospirenon-soderzhaschim-kontratseptivnym-preparatom (дата обращения: 01.05.2024).
Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen / A. L. Coffee, T. J. Kuehl, S. Willis, P. J. Sulak // American Journal of Obstetrics and Gynecology. – 2006. – Т. 195. – Oral contraceptives and premenstrual symptoms. – № 5. – С. 1311-1319.
Claman, F. Premenstrual syndrome and premenstrual dysphoric disorder in adolescence / F. Claman, T. Miller // Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates & Practitioners. – 2006. – Т. 20. – № 5. – С. 329-333.
ПРЕДМЕНСТРУАЛЬНЫЙ СИНДРОМ: КЛИНИКА, ДИАГНОСТИКА, ФИТОТЕРАПИЯ (КЛИНИЧЕСКАЯ ЛЕКЦИЯ) – тема научной статьи по клинической медицине читайте бесплатно текст научно-исследовательской работы в электронной библиотеке КиберЛенинка. – URL: https://cyberleninka.ru/article/n/predmenstrualnyy-sindrom-klinika-diagnostika-fitoterapiya-klinicheskaya-lektsiya (дата обращения: 02.05.2024). – Текст : электронный.
Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials / M. D. van Die, H. G. Burger, H. J. Teede, K. M. Bone // Planta Medica. – 2013. – Т. 79. – Vitex agnus-castus extracts for female reproductive disorders. – № 7. – С. 562-575.
Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis / S. L. Ooi, S. Watts, R. McClean, S. C. Pak // Journal of Women’s Health (2002). – 2020. – Т. 29. – Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia. – № 2. – С. 262-278.
Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study / M. Höller, H. Steindl, D. Abramov-Sommariva [и др.] // Archives of Gynecology and Obstetrics. – 2024. – Т. 309. – Use of Vitex agnus-castus in patients with menstrual cycle disorders. – № 5. – С. 2089-2098.
Dante, G. Herbal treatments for alleviating premenstrual symptoms: a systematic review / G. Dante, F. Facchinetti // Journal of Psychosomatic Obstetrics and Gynaecology. – 2011. – Т. 32. – Herbal treatments for alleviating premenstrual symptoms. – № 1. – С. 42-51.
The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis / S. Verkaik, A. M. Kamperman, R. van Westrhenen, P. F. J. Schulte // American Journal of Obstetrics and Gynecology. – 2017. – Т. 217. – The treatment of premenstrual syndrome with preparations of Vitex agnus castus. – № 2. – С. 150-166.
Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials / D. Csupor, T. Lantos, P. Hegyi [и др.] // Complementary Therapies in Medicine. – 2019. – Т. 47. – Vitex agnus-castus in premenstrual syndrome. – С. 102190.
Agajani Delavar, M. A double-blind placebo-controlled evaluation of Vitex agnus castus in premenstrual syndrome / M. Agajani Delavar, F. Nasiri, S. H. Hoseini. – Text : electronic // Journal of Medicinal Plants. – 2002. – Vol. 1. – № 2. – P. 15-20. – URL: http://jmp.ir/article-1-810-en.html (date accessed: 03.07.2024).
Клиническая характеристика и пути коррекции предменструальных расстройств у девушек-студенток. – URL: https://www.mediasphera.ru/issues/rossijskij-vestnik-akushera-ginekologa/2012/6/031726-61222012614 (дата обращения: 05.09.2024). – Текст : электронный.
Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome / C. Di Carlo, S. Palomba, G. A. Tommaselli [и др.] // Fertility and Sterility. – 2001. – Т. 75. – № 2. – С. 380-384.
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review / K. Wyatt, P. Dimmock, P. Jones [и др.] // BMJ (Clinical research ed.). – 2001. – Т. 323. – Efficacy of progesterone and progestogens in management of premenstrual syndrome. – № 7316. – С. 776-780.
Progesterone for Premenstrual Syndrome / O. Ford, A. Lethaby, B. Mol, H. Roberts // The Cochrane Database of Systematic Reviews. – 2006. – № 4. – С. CD003415.
Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration / W. Vanselow, L. Dennerstein, K. M. Greenwood, B. de Lignieres // Journal of Psychosomatic Obstetrics and Gynaecology. – 1996. – Т. 17. – № 1. – С. 29-38.
Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome / M. Khajehei, K. Abdali, M. E. Parsanezhad, H. R. Tabatabaee // International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics. – 2009. – Т. 105. – № 2. – С. 158-161.
The treatment of premenstrual tension with dydrogesterone (‘Duphaston’): Current Medical Research and Opinion: Vol 4, No sup4. – URL: https://www.tandfonline.com/doi/abs/10.1185/03007997709115299 (дата обращения: 09.09.2024). – Текст : электронный.
Premenstrual syndrome. A double-blind cross-over study of treatment with dydrogesterone and placebo / G. A. Sampson, P. R. Heathcote, J. Wordsworth [и др.] // The British Journal of Psychiatry: The Journal of Mental Science. – 1988. – Т. 153. – С. 232-235.
Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study / M. Wang, S. Hammarbäck, B. A. Lindhe, T. Bäckström // Acta Obstetricia Et Gynecologica Scandinavica. – 1995. – Т. 74. – Treatment of premenstrual syndrome by spironolactone. – № 10. – С. 803-808.
Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group / S. Thys-Jacobs, P. Starkey, D. Bernstein, J. Tian // American Journal of Obstetrics and Gynecology. – 1998. – Т. 179. – Calcium carbonate and the premenstrual syndrome. – № 2. – С. 444-452.
Thys-Jacobs, S. Micronutrients and the premenstrual syndrome: the case for calcium / S. Thys-Jacobs // Journal of the American College of Nutrition. – 2000. – Т. 19. – Micronutrients and the premenstrual syndrome. – № 2. – С. 220-227.
Beneficial Role of Calcium in Premenstrual Syndrome: A Systematic Review of Current Literature / A. Arab, N. Rafie, G. Askari, M. Taghiabadi // International Journal of Preventive Medicine. – 2020. – Т. 11. – Beneficial Role of Calcium in Premenstrual Syndrome. – С. 156.
Premenstrual syndrome and associated symptoms in adolescent girls / O. Derman, N. O. Kanbur, T. E. Tokur, T. Kutluk // European Journal of Obstetrics, Gynecology, and Reproductive Biology. – 2004. – Т. 116. – № 2. – С. 201-206.
Rapkin, A. J. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents / A. J. Rapkin, J. A. Mikacich // Paediatric Drugs. – 2013. – Т. 15. – № 3. – С. 191-202.
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea / J. Marjoribanks, R. O. Ayeleke, C. Farquhar, M. Proctor // The Cochrane Database of Systematic Reviews. – 2015. – Т. 2015. – № 7. – С. CD001751.
Jarvis, C. I. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder / C. I. Jarvis, A. M. Lynch, A. K. Morin // The Annals of Pharmacotherapy. – 2008. – Т. 42. – № 7. – С. 967-978.
Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment - PubMed. – URL: https://pubmed.ncbi.nlm.nih.gov/12691925/ (дата обращения: 02.09.2024). – Текст : электронный.
Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study / F. Facchinetti, L. Fioroni, G. Sances [и др.] // Gynecologic and Obstetric Investigation. – 1989. – Т. 28. – № 4. – С. 205-208.
Физиотерапия в практике акушера-гинеколога - Стругацкий В.М., Маланова Т.Б., Арсланян К.Н. – 2005. – URL: https://rusneb.ru/catalog/010003_000061_69c7faadf3bb312cc4ee90c7b83a4395/ (дата обращения: 01.05.2024). – Текст : электронный.
The treatment of severe premenstrual syndrome with goserelin with and without «add-back» estrogen therapy: a placebo-controlled study / A. T. Leather, J. W. Studd, N. R. Watson, E. F. Holland // Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology. – 1999. – Т. 13. – The treatment of severe premenstrual syndrome with goserelin with and without «add-back» estrogen therapy. – № 1. – С. 48-55.
Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen / I. Sundström, S. Nyberg, M. Bixo [и др.] // Acta Obstetricia Et Gynecologica Scandinavica. – 1999. – Т. 78. – № 10. – С. 891-899.
Методы коррекции предменструального синдрома | #10/07 | «Лечащий врач» – профессиональное медицинское издание для врачей. Научные статьи. – URL: https://www.lvrach.ru/2007/10/4716701?ysclid=m0tz5ovigk426502937 (дата обращения: 08.09.2024). – Текст : электронный.
Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone / L. Dennerstein, C. Morse, G. Gotts [и др.] // Journal of Affective Disorders. – 1986. – Т. 11. – № 3. – С. 199-205.
Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder / B. Segebladh, A. Borgström, S. Nyberg [и др.] // American Journal of Obstetrics and Gynecology. – 2009. – Т. 201. – № 2. – С. 139.e1-8.
Panay, N. Treatment of premenstrual syndrome: a decision-making algorithm / N. Panay // Menopause International. – 2012. – Т. 18. – Treatment of premenstrual syndrome. – № 2. – С. 90-92.
Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women / M. Steiner, A. V. Ravindran, J.-M. LeMelledo [и др.] // The Journal of Clinical Psychiatry. – 2008. – Т. 69. – Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder. – № 6. – С. 991-998.
Lee, J. Practical and illustrated summary of updated BI-RADS for ultrasonography / J. Lee. – Текст : электронный // Ultrasonography. – 2017. – Т. 36. – № 1. – С. 71-81. – URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207351/ (дата обращения: 16.09.2024).